InvestorsHub Logo
Followers 18
Posts 642
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Monday, 11/16/2020 9:35:38 AM

Monday, November 16, 2020 9:35:38 AM

Post# of 403036
Therapeutic vs. Vaccine

Brilacidin is being evaluated as a therapeutic, NOT a vaccine.

The kicker is that, given Brilacidin’s mechanisms (PLURAL) of action, it’s effectiveness is not limited to one novel coronavirus.

Though the news cycle might be overshadowing it, MRSA is still a defined threat, and Brilacidin has the potential to change that, and many other games going forward.

https://www.researchgate.net/publication/281335979_Brilacidin_A_Novel_Antibiotic_Designed_to_Prevent_MRSA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News